Nanobiotix

Research Nanobiotix (5NR) on Bullrun: market cap EUR 1.51B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• Ticker5NR
• ExchangeF
• CountryFrance
• SectorHealthcare
• IndustryBiotechnology
• CurrencyEUR
• Market capEUR 1.51B
• Financial periodFY2025
• RevenueEUR 29.64M
• Revenue growth355.3%
• Net income-EUR 23.96M
• Free cash flow-EUR 33.96M

Valuation Snapshot

latest market cap is EUR 1.51B.

About Nanobiotix

Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck, liver, prostate, pancreatic, esophageal, rectal, and non-small cell lung cancer.

Frequently asked questions

What is Nanobiotix's market cap?

Nanobiotix's market capitalization is EUR 1.51B.

What does Nanobiotix do?

Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs.